$9.62
0.131.37%
Last update: Nov 10, 4:00 PM
MeiraGTx Holdings PLC
MGTXNASDAQ
MeiraGTx rose 8.1% from $8.90 to $9.62, behind the S&P 500's +9.8%. Its worst day was Apr 16 (−15.7%), and its low came Mar 5 at $6.99.
Nov 11, 2025 – Nov 10, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-0.62 missed the $-0.49 estimate on $410,000.00 revenue (est. $5.8M).
−4.6% · S&P 500 −1.7%
MeiraGTx closed at its lowest level of the year, 21.5% below where the year started.
Story events cover the past 12 months · Times ET
−5.7% · S&P 500 −0.6%
EPS of $0.19 beat the $-0.61 estimate on $75.4M revenue (est. $3.2M).
−1.2% · S&P 500 −1.8%
MeiraGTx Holdings plc (NASDAQ: MGTX), a vertically integrated, clinical-stage genetic medicines company, today announced it will host a conference call and webcast to present 3-year data from the long-term follow-up of
+17.2%, the year's best day · S&P 500 +1.2%
EPS of $-0.57 missed the $-0.44 estimate on $293,000.00 revenue (est. $13.9M).
−0.2% · S&P 500 +0.8%
EPS of $1.71 beat the $-0.42 estimate on $321.4M revenue (est. $8.7M).
−2.2% · S&P 500 +0.7%
MeiraGTx shares fell 9.7%, while the S&P 500 fell 4.4%.
−9.7% · S&P 500 −4.4%
Where it ended: a close of $9.62 on Nov 10, 2026. Up next: Q3 2026 earnings on Nov 24, 2026 (EPS est. $-0.47, revenue est. $7.0M).
Nothing in the past 12 months.
All MGTX dividend historyReplay the year: the line draws itself and stops at each of the 7 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for MGTX and SPY from Benzinga historical bars. Not investment advice.
